Cargando…
Serological Protection 5–6 Years Post Vaccination Against Yellow Fever in African Infants Vaccinated in Routine Programmes
Introduction: Although effective live attenuated yellow fever (YF) vaccines have been available for over 9 decades sporadic outbreaks continue to occur in endemic regions. These may be linked to several factors including epidemiological factors such as vector and intermediate host distribution or va...
Autores principales: | Idoko, Olubukola T., Domingo, Cristina, Tapia, Milagritos D., Sow, Samba O., Geldmacher, Christof, Saathoff, Elmar, Kampmann, Beate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578390/ https://www.ncbi.nlm.nih.gov/pubmed/33133096 http://dx.doi.org/10.3389/fimmu.2020.577751 |
Ejemplares similares
-
Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Coadministered With Measles, Yellow Fever, and Meningitis A Vaccines in 9-Month-Old Malian Infants
por: Haidara, Fadima C, et al.
Publicado: (2018) -
Assessing Vaccine Coverage and Timeliness in Bamako, Mali after the Introduction of Rotavirus Vaccine: A Modified Immunization Cluster Survey
por: Roose, Anna, et al.
Publicado: (2021) -
Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study
por: Domingo, Cristina, et al.
Publicado: (2019) -
Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials
por: Idoko, Olubukola T., et al.
Publicado: (2015) -
Yellow fever outbreaks, vaccine shortages and the Hajj and Olympics: call for global vigilance
por: Elachola, Habida, et al.
Publicado: (2016)